Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.

Background: The goal of this study was to identify a clinical biomarker signature of brain amyloidosis in the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) mild cognitive impairment (MCI) cohort.Methods: We developed a multimodal biomarker classifier for predicting brain amyloidosis using co...

Descripción completa

Detalles Bibliográficos

Publicado en:	Neurology Vol. 84; no. 7; pp. 729 - 738
Autores principales:	Apostolova, Liana G, Hwang, Kristy S, Avila, David, Elashoff, David, Kohannim, Omid, Teng, Edmond, Sokolow, Sophie, Jack, Clifford R, Jagust, William J, Shaw, Leslie, Trojanowski, John Q, Weiner, Michael W, Thompson, Paul M
Formato:	research Journal Article
Publicado:	Lippincott Williams & Wilkins 2/17/2015
Acceso en línea:	Ver este registro en EBSCOhost